Vitamin A: Modulating Effect on Breast Carcinogenesis

Author(s): Thaís R. Nogueira*, Victor A. de Oliveira, Irislene C. Pereira, Cecília Maria Resende G. de Carvalho, Gilmara Péres-Rodrigues, Maria do Carmo de Carvalho e Martins, Karoline de Macedo G. Frota, Adriana de Azevedo Paiva, Betânia de Jesus e Silva de Almendra Freitas

Journal Name: Current Nutrition & Food Science

Volume 17 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Breast cancer has a multifactorial etiology and, among the main causal factors, the dietary profile stands out, mainly the components of the pro-inflammatory diet and their interaction with genetic characteristics. In this sense, deciphering the molecular networks involved in the proliferation of cancer cells in breast tissue can determine ways of action of organic compounds that modulate the pathogenesis of cancer, such as vitamin A and analogs, as well as their possible mechanisms of modulation of breast tumorigenesis. This is a review study conducted according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and by consulting the PubMed and Web of Science databases including articles, published in Portuguese, English and Spanish, in the last five years. 126 articles were obtained, of which 13 were selected for full analysis and only 6 were included in the study for meeting the eligibility criteria. The results of the compiled studies demonstrate the role of some retinol-binding proteins in metabolism, as well as in differentiation, cell proliferation and inflammation. Although controversial, the results point to the use of these proteins as possible prognostic markers. The need for further studies in humans is also emphasized in order to assess the main effects of vitamin isoforms on tumor activity.

Keywords: Breast cancer, diet, inflammation, isoforms, retinol, tumorigenesis.

[1]
INCA – Instituto Nacional do Câncer Estimativa 2020: Incidência de Câncer no Brasil/Instituto Nacional de Câncer José Alencar Gomes da Silva Coordenação de Prevenção e Vigilância. Rio de Janeiro: INCA 2019.
[2]
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[http://dx.doi.org/10.3322/caac.21492] [PMID: 30207593]
[3]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2): 87-108.
[http://dx.doi.org/10.3322/caac.21262] [PMID: 25651787]
[4]
Chen SI, Hsieh CC. Why are women with obesity more likely to develop breast cancer. Future Oncol 2018; 14(16): 1523-6.
[http://dx.doi.org/10.2217/fon-2018-0125] [PMID: 29938526]
[5]
Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book 2013; 33: 46-51.
[http://dx.doi.org/10.1200/EdBook_AM.2013.33.46] [PMID: 23714453]
[6]
Mokbel K, Mokbel K. Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review. In Vivo 2019; 33(4): 983-97.
[http://dx.doi.org/10.21873/invivo.11568] [PMID: 31280187]
[7]
BRASIL Ministério da Saúde (BR) Manual de Bases Técnicas de Oncologia – SIA/SUS – Sistema de Informações Ambulatoriais. Brasília, DF: Ministério da Saúde 2011.
[8]
INCA - Instituto Nacional do Câncer Ações de enfermagem para o controle do câncer: uma proposta de integração ensino-serviço. Rio de Janeiro: INCA 2008.
[9]
Suhail N, Bilal N, Khan HY, et al. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy. J Clin Pharm Ther 2012; 37(1): 22-6.
[http://dx.doi.org/10.1111/j.1365-2710.2010.01237.x] [PMID: 21204889]
[10]
Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297(8): 842-57.
[http://dx.doi.org/10.1001/jama.297.8.842] [PMID: 17327526]
[11]
Elshal M, Abu-Elsaad N, El-Karef A, et al. Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration. Int Immunopharmacol 2019; 75105808
[http://dx.doi.org/10.1016/j.intimp.2019.105808] [PMID: 31419710]
[12]
Nattenmüller CJ, Kriegsmann M, Sookthai D, et al. Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study. BMC Cancer 2018; 18(1): 616.
[http://dx.doi.org/10.1186/s12885-018-4548-6] [PMID: 29855282]
[13]
Hu X, Li S, Zhou L, et al. Effect of vitamin E supplementation on uterine cervical neoplasm: a meta-analysis of case-control studies. PLoS One 2017; 12(8)e0183395
[http://dx.doi.org/10.1371/journal.pone.0183395] [PMID: 28829815]
[14]
Mowbray PK, Wilkinson A, Tse HHM. An integrative review of employee voice: identifying a common conceptualization and research agenda. Int J Manag Rev 2014; 17(3): 382-400.
[15]
Liu R-Z, Garcia E, Glubrecht DD, et al. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid. Mol Cancer 2015; 14: 129.
[http://dx.doi.org/10.1186/s12943-015-0380-7] [PMID: 26142905]
[16]
Larouche D, Hanna M, Chang S-L, et al. Evaluation of antioxidant intakes in relation to inflammatory markers expression within the normal breast tissue of breast cancer patients. Integr Cancer Ther 2017; 16(4): 485-95.
[http://dx.doi.org/10.1177/1534735416676584] [PMID: 27903840]
[17]
Lin G, Zhu S, Wu Y, et al. ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines. Sci Rep 2017; 7(1): 2929.
[http://dx.doi.org/10.1038/s41598-017-03231-9] [PMID: 28592877]
[18]
Perri M, Caroleo MC, Liu N, et al. 9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models. Exp Cell Res 2017; 354(1): 25-30.
[http://dx.doi.org/10.1016/j.yexcr.2017.03.022] [PMID: 28300567]
[19]
Mezquita B, Mezquita P, Pau M, et al. All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action. Sci Rep 2018; 8(1): 7047.
[http://dx.doi.org/10.1038/s41598-018-25526-1] [PMID: 29728589]
[20]
Vahid F, Hatami M, Sadeghi M, et al. The association between the Index of Nutritional Quality (INQ) and breast cancer and the evaluation of nutrient intake of breast cancer patients: a case-control study. Nutrition 2018; 45: 11-6.
[http://dx.doi.org/10.1016/j.nut.2017.06.011] [PMID: 29129231]
[21]
Barber T, Esteban-Pretel G, Marín MP, et al. Vitamin A deficiency and alterations in the extracellular matrix. Nutrients 2014; 6(11): 4984-5017.
[http://dx.doi.org/10.3390/nu6114984] [PMID: 25389900]
[22]
Napoli JL. Functions of intracellular retinoid binding-proteins. Subcell Biochem 2016; 81: 21-76.
[http://dx.doi.org/10.1007/978-94-024-0945-1_2] [PMID: 27830500]
[23]
Doldo E, Costanza G, Agostinelli S, et al. Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins. BioMed Res Int 2015; 2015624627
[http://dx.doi.org/10.1155/2015/624627] [PMID: 25879031]
[24]
Napoli JL. Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases. Pharmacol Ther 2017; 173: 19-33.
[http://dx.doi.org/10.1016/j.pharmthera.2017.01.004] [PMID: 28132904]
[25]
Jiang Q, Pan Y, Cheng Y, et al. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways. Oncol Rep 2016; 36(1): 253-62.
[http://dx.doi.org/10.3892/or.2016.4798] [PMID: 27175819]
[26]
Wang F, Yang Y, Fu Z, et al. Differential DNA methylation status between breast carcinomatous and normal tissues. Biomed Pharmacother 2014; 68(6): 699-707.
[http://dx.doi.org/10.1016/j.biopha.2014.07.014] [PMID: 25070394]
[27]
Bushue N, Wan Y-JY. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev 2010; 62(13): 1285-98.
[http://dx.doi.org/10.1016/j.addr.2010.07.003] [PMID: 20654663]
[28]
Ci Y, Qiao J, Han M. Molecular mechanisms and metabolomics of natural polyphenols interfering with breast cancer metastasis. Molecules 2016; 21(12): 1634.
[http://dx.doi.org/10.3390/molecules21121634] [PMID: 27999314]
[29]
Tang XH, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol 2011; 6: 345-64.
[http://dx.doi.org/10.1146/annurev-pathol-011110-130303] [PMID: 21073338]
[30]
Das BC, Thapa P, Karki R, et al. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem 2014; 22(2): 673-83.
[http://dx.doi.org/10.1016/j.bmc.2013.11.025] [PMID: 24393720]
[31]
Niles RM. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 2004; 555(1-2): 81-96.
[http://dx.doi.org/10.1016/j.mrfmmm.2004.05.020] [PMID: 15476854]
[32]
Stevison F, Jing J, Tripathy S, et al. Role of retinoic acid metabolizing cytochrome P450s, CYP26, in inflammation and cancer. Adv Pharmacol 2015; 74: 373-412.
[http://dx.doi.org/10.1016/bs.apha.2015.04.006] [PMID: 26233912]
[33]
Kainov Y, Favorskaya I, Delektorskaya V, et al. CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors. Cell Cycle 2014; 13(10): 1530-9.
[http://dx.doi.org/10.4161/cc.28475] [PMID: 24626200]
[34]
Miyake T, Ueda Y, Matsuzaki S, et al. CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma. J Cancer Res Clin Oncol 2011; 137(4): 715-22.
[http://dx.doi.org/10.1007/s00432-010-0930-8] [PMID: 20571827]
[35]
Pfoertner S, Goelden U, Hansen W, et al. Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol 2005; 26(6): 313-23.
[http://dx.doi.org/10.1159/000089262] [PMID: 16254461]
[36]
Tanaka K, Imoto I, Inoue J, et al. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007; 26(44): 6456-68.
[http://dx.doi.org/10.1038/sj.onc.1210459] [PMID: 17438526]
[37]
Feng X, Zhang M, Wang B, et al. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status. J Exp Clin Cancer Res 2019; 38(1): 361.
[http://dx.doi.org/10.1186/s13046-019-1345-2] [PMID: 31419991]
[38]
Dutta A, Sen T, Banerji A, et al. Studies on multifunctional effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7). J Oncol 2009; 2009627840
[http://dx.doi.org/10.1155/2009/627840] [PMID: 19636436]
[39]
Ju J, Wang N, Wang J, et al. 4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5. Drug Des Devel Ther 2018; 12: 997-1008.
[http://dx.doi.org/10.2147/DDDT.S151029] [PMID: 29731607]
[40]
Dong JY, He K, Wang P, et al. Dietary fiber intake and risk of breast cancer: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2011; 94(3): 900-5.
[http://dx.doi.org/10.3945/ajcn.111.015578] [PMID: 21775566]
[41]
Sessler RJ, Noy N. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell 2005; 18(3): 343-53.
[http://dx.doi.org/10.1016/j.molcel.2005.03.026] [PMID: 15866176]
[42]
Tavares V, Hirata MH, Hirata RDC. Receptor ativado por proliferadores de peroxissoma gama (PPARgama): estudo molecular na homeostase da glicose, metabolismo de lipídeos e abordagem terapêutica. Arq Bras Endocrinol Metabol 2007; 51(4): 526-33.
[http://dx.doi.org/10.1590/S0004-27302007000400005] [PMID: 17684612]
[43]
Schug TT, Berry DC, Shaw NS, et al. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007; 129(4): 723-33.
[http://dx.doi.org/10.1016/j.cell.2007.02.050] [PMID: 17512406]
[44]
Schug TT, Berry DC, Toshkov IA, et al. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci USA 2008; 105(21): 7546-51.
[http://dx.doi.org/10.1073/pnas.0709981105] [PMID: 18495924]
[45]
He B, Lee LW, Minges JT, et al. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem 2002; 277(28): 25631-9.
[http://dx.doi.org/10.1074/jbc.M202809200] [PMID: 12000757]
[46]
Nascimento AS, Dias SM, Nunes FM, et al. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J Mol Biol 2006; 360(3): 586-98.
[http://dx.doi.org/10.1016/j.jmb.2006.05.008] [PMID: 16781732]
[47]
Rogerson FM, Fuller PJ. Mineralocorticoid action. Steroids 2000; 65(2): 61-73.
[http://dx.doi.org/10.1016/S0039-128X(99)00087-2] [PMID: 10639017]
[48]
Peters JM, Foreman JE, Gonzalez FJ. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis. Cancer Metastasis Rev 2011; 30(3-4): 619-40.
[http://dx.doi.org/10.1007/s10555-011-9320-1] [PMID: 22037942]
[49]
Peters JM, Shah YM, Gonzalez FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 2012; 12(3): 181-95.
[http://dx.doi.org/10.1038/nrc3214] [PMID: 22318237]
[50]
Yao P-L, Morales JL, Zhu B, et al. Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity. Mol Cancer Ther 2014; 13(4): 1008-17.
[http://dx.doi.org/10.1158/1535-7163.MCT-13-0836] [PMID: 24464939]
[51]
Liu R-Z, Graham K, Glubrecht DD, et al. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am J Pathol 2011; 178(3): 997-1008.
[http://dx.doi.org/10.1016/j.ajpath.2010.11.075] [PMID: 21356353]
[52]
Portantiolo TN, Vale IAV, Bergmann RB, et al. Consumo de Vitaminas Antioxidantes por Mulheres com Câncer de Mama submetidas ao Tratamento Quimioterápico na Cidade de Pelotas-RS. Rev Bras Cancerol 2014; 60: 323-9.
[http://dx.doi.org/10.32635/2176-9745.RBC.2014v60n4.450]
[53]
Ramalho A. Vitamina A: ILSI Brasil International Life Sciences. Série de publicações. ILSI BRASIL: Funções plenamente reconhecidas de nutrientes 2014. 4
[54]
Tesoriere L, D’Arpa D, Re R, et al. Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration. Arch Biochem Biophys 1997; 343(1): 13-8.
[http://dx.doi.org/10.1006/abbi.1997.0128] [PMID: 9210641]
[55]
Barreiros ALBS, David JM. Estresse oxidativo: relação entre geração de espécies reativas e defesa do organismo. Quim Nova 2006; 29: 113-23.
[http://dx.doi.org/10.1590/S0100-40422006000100021]
[56]
Palace VP, Khaper N, Qin Q, et al. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med 1999; 26(5-6): 746-61.
[http://dx.doi.org/10.1016/S0891-5849(98)00266-4] [PMID: 10218665]
[57]
Jason J, Archibald LK, Nwanyanwu OC, et al. Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol 2002; 9(3): 616-21.
[PMID: 11986269]
[58]
Gross V, Villiger PM, Zhang B, et al. Retinoic acid inhibits interleukin-1-induced cytokine synthesis in human monocytes. J Leukoc Biol 1993; 54(2): 125-32.
[http://dx.doi.org/10.1002/jlb.54.2.125] [PMID: 8360592]
[59]
Bonner MY, Arbiser JL. The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer. Future Med Chem 2014; 6(12): 1413-22.
[http://dx.doi.org/10.4155/fmc.14.86] [PMID: 25329197]
[60]
Wu X, An X, Zhang C, et al. Clb6-Cdc28 promotes ribonucleotide reductase subcellular redistribution during S phase. Mol Cell Biol 2018; 38(6): e00497-17.
[PMID: 29263158]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 2
Year: 2021
Published on: 05 July, 2020
Page: [196 - 203]
Pages: 8
DOI: 10.2174/1573401316999200706011813
Price: $65

Article Metrics

PDF: 16
HTML: 1